A detailed history of Hrt Financial LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Hrt Financial LP holds 189,571 shares of ABBV stock, worth $38.6 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
189,571
Holding current value
$38.6 Million
% of portfolio
0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $29.3 Million - $34.3 Million
189,571 New
189,571 $32.5 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $1.25 Million - $1.41 Million
9,073 New
9,073 $1.41 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $25.5 Million - $31.7 Million
192,074 New
192,074 $25.9 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $5.92 Million - $7.52 Million
42,982 New
42,982 $6.58 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $14.6 Million - $16.5 Million
-136,812 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $14.4 Million - $16 Million
136,812 New
136,812 $15.4 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $2.38 Million - $3.61 Million
-36,877 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.97 Million - $2.47 Million
27,319 Added 285.82%
36,877 $3.27 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $1.91 Million - $2.3 Million
-30,383 Reduced 76.07%
9,558 $723,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $2.43 Million - $3.11 Million
36,996 Added 1256.23%
39,941 $2.9 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $223,628 - $263,200
-2,899 Reduced 49.61%
2,945 $237,000
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $187,929 - $231,768
2,414 Added 70.38%
5,844 $538,000
Q3 2018

Nov 15, 2018

BUY
$88.91 - $98.84 $76,818 - $85,397
864 Added 33.67%
3,430 $324,000
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $230,375 - $272,586
2,566 New
2,566 $237,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.